Patents by Inventor Christopher M. Sassetti

Christopher M. Sassetti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Selectin ligands
    Patent number: 6395882
    Abstract: Podocalyxin like proteins (e.g. PCLP and PCLP-2) having selectin ligand activity are provided. Also provided are nucleic acid compositions encoding novel PCLP-2 proteins. The subject polypeptide and nucleic acid compositions find use in a variety of applications, including research, diagnostic, and therapeutic agent screening applications, as well as in treatment therapies for disease conditions associated with podocalyxin like protein activity. In particular, methods of treating diseases associated with podocalyxin like protein selectin binding activity and/or chemokine presenting activity are provided, where such diseases include inflammation and the like.
    Type: Grant
    Filed: February 3, 1999
    Date of Patent: May 28, 2002
    Assignee: The Regents of the University of California
    Inventors: Steven D. Rosen, Christopher M. Sassetti
  • Endoglycan: a novel protein having selectin ligand and chemokine presentation activity
    Patent number: 6380371
    Abstract: Nucleic acid compositions encoding novel endoglycan proteins, as well as the novel endoglycan proteins, are provided. Also provided are methods of producing the subject nucleic acid and protein compositions. The subject polypeptide and nucleic acid compositions find use in a variety of applications, including diagnostic and therapeutic agent screening applications, as well as in treatment therapies for disease conditions associated with endoglycan activity. In particular, methods of treating diseases associated with endoglycan selectin binding activity and/or chemokine presenting activity are provided, where such diseases include inflammation and the like.
    Type: Grant
    Filed: September 13, 1999
    Date of Patent: April 30, 2002
    Assignee: The Regents of the University of California
    Inventors: Christopher M. Sassetti, Steven D. Rosen
  • Novel selection ligands
    Publication number: 20020025923
    Abstract: Podocalyxin like proteins (e.g. PCLP and PCLP-2) having selectin ligand activity are provided. Also provided are nucleic acid compositions encoding novel PCLP-2 proteins. The subject polypeptide and nucleic acid compositions find use in a variety of applications, including research, diagnostic, and therapeutic agent screening applications, as well as in treatment therapies for disease conditions associated with podocalyxin like protein activity. In particular, methods of treating diseases associated with podocalyxin like protein selectin binding activity and/or chemokine presenting activity are provided, where such diseases include inflammation and the like.
    Type: Application
    Filed: May 18, 2001
    Publication date: February 28, 2002
    Inventors: Steven D. Rosen, Christopher M. Sassetti